Core Viewpoint - The company is utilizing idle raised funds for cash management by investing in principal-protected floating income products, aiming to enhance returns while ensuring that it does not affect the normal operations and investment projects of the company [2][4][11]. Group 1: Cash Management Details - The company has approved the use of up to 43,000.00 million RMB of idle raised funds for cash management, with a rolling usage period of 12 months from the board's approval date [2][9]. - The company redeemed principal of 42,400 million RMB from previously purchased floating income products, yielding a profit of 1,589,128.78 RMB [3][4]. - The cash management is primarily aimed at purchasing principal-protected floating income products amounting to 40,900.00 million RMB [5][10]. Group 2: Financial Background - The total raised funds amounted to 93,336.96 million RMB, with a net amount of 84,163.14 million RMB after deducting issuance costs [7]. - The cash management investment of 40,900.00 million RMB represents 92.38% of the company's cash balance as of September 30, 2024, which was 442,755,118.57 RMB [11]. Group 3: Risk Control Measures - The company has established internal controls to manage risks associated with cash management, including selecting reputable financial institutions and maintaining oversight by independent directors and the supervisory board [8][10]. - The company will regularly report investment status to the board and take necessary actions if adverse factors are identified [10][11].

Group 1 - The company approved the permanent use of surplus funds from the "Gaoming Plant Phase II Expansion Project" amounting to 10.50 million yuan for daily operations [1] - As of December 31, 2024, the company has no surplus funds in use [2] - The balance of unused raised funds as of December 31, 2024, is 627.50 million yuan, including 67.50 million yuan in demand deposits and 560 million yuan in time deposits [3] Group 2 - The company extended the timeline for the "Zhongqi (Hubei) New Materials Phase I Construction Project" and "R&D Center Information Technology Construction Project" to August 31, 2024 [4] - The timeline for the "Luocheng Phase I" project was extended to September 30, 2025 [4] Group 3 - The company proposed to change the use of remaining funds from the "R&D Center and Information Technology Construction Project" to "High Purity Quartz Sand R&D Center and Information Technology Construction Project" with an amount of 43.30 million yuan [5] - The remaining funds from the "Zhongqi (Hubei) New Materials Phase I and II Construction Projects" will be redirected to a new project for producing 10,000 tons of semiconductor-grade and photovoltaic crucibles, amounting to 239.44 million yuan [5] Group 4 - The company used idle raised funds to purchase financial products, exceeding the authorized limit of 500 million yuan, with a maximum amount of 570 million yuan during the period from May 9, 2024, to April 23, 2025 [7] - The company has taken measures to ensure compliance with fund management regulations and prevent similar occurrences in the future [7][8] Group 5 - The company has disclosed all relevant information in a timely and accurate manner, and all used raised funds have been directed to the promised investment projects without significant violations [8] Group 6 - The company plans to use up to 600 million yuan of idle raised funds and 300 million yuan of self-owned funds for cash management, totaling 900 million yuan [66] - The cash management will focus on high-security, high-liquidity products with a maximum investment period of 12 months [72]

目前，国联民生各项业务整合工作稳步推进中。国联民生全资子公司华英证券吸纳民生证券的投行 板块后，近日更名为国联民生承销保荐，注册地由无锡迁至上海。 吸纳民生投行板块后更名 4月22日，国联民生全资子公司华英证券完成名称变更登记手续，其名称由"华英证券有限责任公 司"变更为"国联民生证券承销保荐有限公司"，并取得了上海市市场监督管理局换发的营业执照。 华英证券为国联民生证券全资子公司，成立于2011年4月，专业从事股票和债券的承销与保荐业 务，以及企业收购兼并、资产重组财务顾问等中国证监会批准的其他业务。公司总部设在无锡。 据国联民生介绍，目前，国联民生各项业务整合工作稳步推进中。前有民生并入国联，无锡市证券 实力增强，上海流失一家券商。后有华英吸纳民生证券的投行板块，更名国联民生承销保荐，注册地由 无锡迁址上海。在看似"失之东隅，收之桑榆"的背后，实则为沪锡两地携手推进长三角一体化发展的创 新尝试。 信息显示，更名后的国联民生承销保荐注册资本为2亿元，法定代表人为葛小波，注册地为上海。 截至2024年期末，华英证券总资产 7.7 亿元，净资产3.59亿元；2024年利润总额225.67万元，净利 润-401. ...

Fund Management and Usage - As of December 31, 2024, the balance of the special account for raised funds is reported [1] - The company has used a total of 115,179,363.72 CNY of raised funds to replace self-raised funds for investment projects and issuance expenses, approved by the board and supervisory committee [2] - There were no instances of using idle raised funds to temporarily supplement working capital during the reporting period [3] Cash Management of Idle Funds - The company approved the use of up to 300 million CNY of temporarily idle raised funds for cash management, investing in low-risk, liquid financial products [4][5] - The cash management plan allows for rolling use of funds within the approved limit, with individual product investment periods not exceeding 12 months [4][5] Project Investment and Adjustments - The company has not used any over-raised funds for permanent working capital supplementation or loan repayment during the reporting period [7] - There are no surplus raised funds as the investment process is ongoing, and no changes have occurred in the planned use of raised funds [7][8] Audit and Compliance - The report on the management and usage of raised funds has been verified by Lixin Accounting Firm, confirming compliance with regulatory requirements [6][8] - The company has disclosed all relevant information accurately and timely, with no significant violations in the use of raised funds [7][8] Asset Impairment Provision - The company has recognized an asset impairment loss totaling 120,506,931.94 CNY for the year 2024, based on comprehensive asset evaluations [30][33] - The impairment includes credit losses, inventory write-downs, and losses on investment properties and fixed assets [31][32][33] Project Delay Announcement - The company has announced a delay in the "Research and Development Center Construction Project," extending the expected completion date to May 2026 due to design adjustments and permit acquisition [38][40] - The project is deemed necessary and feasible, with a focus on enhancing the company's capabilities in large-scale cryogenic equipment [41][43]

登录新浪财经APP 搜索【信披】查看更多考评等级 根据中国证券监督管理委员会出具的《关于同意北京阳光诺和药物研究股份有限公司首次公开发行股票 注册的批复》（证监许可【2021】1629号），同意北京阳光诺和药物研究股份有限公司（以下简称"阳 光诺和"、"公司"）首次公开发行股票的注册申请，公司获准向社会公开发行人民币普通股20,000,000 股。每股面值为1元，每股发行价格为26.89元，募集资金总额537,800,000.00元。上述募集资金总额扣除 发行费用70,618,507.55元（相关费用均为不含税金额）后，本次公司公开发行新股的募集资金净额 467,181,492.45元。本次发行证券已于2021年6月21日在上海证券交易所科创板上市。民生证券股份有限 公司（以下简称"保荐机构"或"民生证券"）担任其持续督导保荐机构，持续督导期间为2021年6月21日 至2024年12月31日。 2024年12月31日，持续督导期已届满，民生证券根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第1号一一规范运作》等法 规、规范性文件相关要求，出 ...

中国经济网北京4月8日讯科净源（301372）(301372.SZ)昨晚发布关于收到中国证券监督管理委员会立 案告知书的公告。北京科净源科技股份有限公司于近日收到中国证券监督管理委员会(以下简称"中国证 监会")《立案告知书》(编号：证监立案字0142025023号)，因涉嫌信息披露违法违规，根据《中华人民 共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司进行立案。 经公司自查发现，公司全资子公司北京科净源设备安装工程有限公司(以下简称"安装公司")存在对外担 保未及时履行审批程序和信息披露义务的情形。公司在发现上述对外担保事项后第一时间成立专项核查 小组，根据调查结果，对相关责任人员进行处罚，责令相关人员吸取教训、总结经验。要求公司所有部 门和全体员工高度重视，强化责任担当，认真履职。截至2024年3月31日，上述对外担保已经全部解除 完毕。 针对上述事项，公司及时进行了整改规范，具体整改措施如下： 1、解除全部子公司银行定期存单质押 截至2024年3月31日，公司前述银行定期存单质押已全部解除，公司不存在其他银行定期存单质押的情 形。 2、对相关人员进行内部问责 成立以董事长为组 ...

Core Points - The company Yantai Eddie Precision Machinery Co., Ltd. will begin paying interest on its convertible bonds on April 15, 2025, for the period from April 15, 2024, to April 14, 2025 [2][18] - The convertible bonds were issued on April 15, 2022, with a total issuance size of 1 billion RMB (100,000 million) and a total of 10 million bonds [6][8] - The bonds have a maturity period of six years, from April 15, 2022, to April 14, 2028, with an annual interest rate that increases over the years [9][10] Convertible Bond Details - The bond name is "2022 Yantai Eddie Precision Machinery Co., Ltd. Publicly Issued Convertible Bonds" with the code 113644 [2][4] - The initial conversion price is set at 23.96 RMB per share, with the latest conversion price at 23.63 RMB per share [13] - The bonds are rated AA- by China Chengxin International Credit Rating Co., Ltd. [14][15] Interest Payment Information - The interest rate for the third year is 1.0%, meaning each bond with a face value of 100 RMB will yield an interest payment of 1.00 RMB (before tax) [10][18] - The interest payment record date is April 14, 2025, with the payment date on April 15, 2025 [18] - Investors will receive the net interest amount after a 20% personal income tax deduction, resulting in an actual payment of 0.80 RMB per bond [20] Payment Method and Taxation - The company has appointed China Securities Depository and Clearing Corporation Limited Shanghai Branch to handle the bond interest payments [19] - Individual investors are responsible for paying the personal income tax on the interest income, while corporate investors will handle their own tax obligations [20][21]

证券代码：688173 证券简称：希荻微 公告编号：2025-021 希荻微电子集团股份有限公司 前次募集资金使用情况报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会《监管规则适用指引——发行类第 7 号》的相 关规定，希荻微电子集团股份有限公司（以下简称"公司"或"希荻微"）将截 至 2024 年 10 月 31 日止前次募集资金使用情况报告如下： 一、前次募集资金基本情况 （一）前次募集资金金额、资金到位情况 经中国证券监督管理委员会《关于同意广东希荻微电子股份有限公司首次公 开发行股票注册的批复》（证监许可20213934号）同意注册，并经上海证券交 易所同意，公司向社会公众公开发行人民币普通股4,001万股，每股面值人民币 扣除发行费用后的募集资金净额为人民币122,140.85万元。上述募集资金已全部 到位，业经普华永道中天会计师事务所（特殊普通合伙）予以验证，并出具了普 华永道中天验字（2022）第0095号《广东希荻微电子股份有限公司首次公开发行 人民币普通股A股验资报告》。 ...

免责声明： 本报告仅供本公司境内客户使用。本公司不会因接收人收到本报告而视其为客户。本报告仅 为参考之用，并不构成对客户的投资建议，不应被视为买卖任何证券、金融工具的要约或要 约邀请。本报告所包含的观点及建议并未考虑个别客户的特殊状况、目标或需要，客户应当 充分考虑自身特定状况，不应单纯依靠本报告所载的内容而取代个人的独立判断。在任何情 民生证券股份有限公司（以下简称"本公司"）具有中国证监会许可的证券投资咨询业务资 格。 ...

Group 1 - Company Shenyu Co., Ltd. plans to issue convertible bonds to unspecified investors, aiming to raise up to RMB 50 million for smart data line construction projects [1][3] - The total investment for the smart data line construction project is RMB 50.426 billion, with the entire amount raised from the bond issuance allocated to this project [3][4] - The convertible bonds will be issued at par value, with a face value of RMB 100 each and a maturity of six years from the issuance date [3][4] Group 2 - The bondholders will have the option to convert their bonds into A-shares starting six months after the issuance, with conversion rights allowing them to become shareholders [4] - The issuance will prioritize existing shareholders, who can choose to waive their preemptive rights, with the remaining bonds offered to institutional investors [4][8] - The company reported a revenue of RMB 877.1 million for 2024, a year-on-year increase of 16.17%, and a net profit attributable to shareholders of RMB 79.54 million, up 57.67% [5][6] Group 3 - The net cash flow from operating activities for the company reached RMB 94.29 million, a significant increase compared to the previous year's negative cash flow [6] - The company’s total assets as of the end of 2024 were RMB 1.314 billion, reflecting a 2.33% increase from the previous year [6] - The actual controllers of the company plan to reduce their shareholdings by up to 1.75 million shares, which is 0.99% of the total share capital, without affecting the company's control [7]